FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Peer Review reports

Original Submission
6 Jan 2014	Submitted	Original manuscript
29 Jan 2014	Reviewed	Reviewer Report - Marco BL Rocchi
26 Feb 2014	Reviewed	Reviewer Report - Patricia de Cremoux
30 Mar 2014	Author responded	Author comments - Janne Beathe Kjersem
Resubmission - Version 2
30 Mar 2014	Submitted	Manuscript version 2
1 May 2014	Author responded	Author comments - Janne Beathe Kjersem
Resubmission - Version 3
1 May 2014	Submitted	Manuscript version 3
Publishing
9 May 2014	Editorially accepted
19 May 2014	Article published	10.1186/1471-2407-14-340

Back to article page